Kirk Michel - Jan 4, 2022 Form 4 Insider Report for Pharma-Bio Serv, Inc. (PBSV)

Role
Chairman, Director
Signature
/s/ Kirk Michel
Stock symbol
PBSV
Transactions as of
Jan 4, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 07:14 PM
Next filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBSV Common Stock Options Exercise $18.2K +20K +61.15% $0.91 52.7K Jan 4, 2022 Direct
transaction PBSV Common Stock Tax liability -$18.2K -17.7K -33.53% $1.03 35K Jan 4, 2022 Direct F1, F2
holding PBSV Common Stock 341K Jan 4, 2022 By Kema Advisors, Inc. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBSV Stock Option Options Exercise $0 -20K -100% $0.00* 0 Jan 4, 2022 Common Stock 20K $0.91 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
F2 Shares reported in this column have been updated to properly reflect the shares held by the reporting person following the transactions on January 4, 2021.
F3 The reporting person is the sole shareholder of this entity.
F4 The option vested in two equal installments on July 10, 2017 and July 10, 2018.